Kalos Medical Announces Promotion of Seokjoo Chang, Ph.D. to Co-Chief Executive Officer
Further Announces Engagement of Checkmate Capital Group as International Advisor LOS ANGELES and SEOUL, South Korea, Dec. 06, 2022 ...
Enrollment Commences in Two Large, Double-Blind Trials of eTNS for Pediatric ADHD
Trials recruiting subjects at UCLA and Seattle Children’s Hospital in the United States, and at King’s College London and the ...
NeuroSigma Announces Commercial Launch of The Monarch eTNS® System
NeuroSigma Announces Commercial Launch of The Monarch eTNS® System for the Treatment of Pediatric ADHD at Annual Meeting of the...